TO THE QUESTION OF CHOOSING A NAME FOR A MEDICINAL PRODUCT
Keywords:trademark, intellectual property, naming, trade name, generics.
This paper presents an analysis of the features of naming in the pharmaceutical industry in the Russian Federation. The article examines the role of INN status in the creation of innovative drugs, as well as the importance of such identification means as a trademark, trade name in the formation and development of new drug brands in the Russian and international markets. Attention is drawn to the need to create a national system for expert selection of non-proprietary names and legislative consolidation of the legal protection of INN and INN, as well as the implementation of strict control by the state.
Civil Code of the Russian Federation. Part 4) from 18.12.2006 N230-FZ (as amended on 07/03/2016) // Parliamentary newspaper. 12/21/2006. N 214, 215
State reform program "Pharma 2020". M .: October, 2009, 70 p.
Egorov VA, Abdulmanova EL History of pharmacy: a textbook for students of the pharmaceutical faculty. Samara: OOO "Etching", GOUVPO "SamGMU" 2nd edition, 2004
Radchenko N.A. Homogeneity and its impact on the fate of the trademark "Journal of the Intellectual Property Rights Court", No. 8, June 2015, from. 49-58
Zanina I.A., Razdorskaya I.M. The concept of "Brand" in the pharmaceutical market: the meaning and relationship with the main means of drug identification. VSU Bulletin, Series: Chemistry. Biology. Pharmacy. 2017. No. 4. S. 112-116.
Information letter dated November 5, 2008 No. 10/37 - 646/23 "On the classification of biologically active food additives in accordance with the International Classification of Goods and Services and on the establishment of their homogeneity with other goods and services for the purpose of registration of trademarks."
Loshakov L.A. System of international and national generic names of medicines. // Bulletin Roszdravnadzor. 2008, No. 6. S. 31-33.
Natradze, A.G. ... Chemical and pharmaceutical industry - medicine. - M .: Knowledge, 1985, 64 p.
National priority project "Health". M .: Prof, 2008, 327 p.
On international non-proprietary names materials from the site http://www.antibiotic.ru/cmac/pdf/9 2 121.pdf).
Pogrebnyak A.V. Molecular modeling and design of biologically active substances. Rostov-on-Don: Publishing house SKNTs VSh, 2003. - 229 p.
Ministry of Health and Social Development Russia, Roszdravnadzor MZiSR. Order of the Ministry of Health of Russia No. 429 dated June 29, 2016 "On approval of the Rules for the rational choice of names of drugs for medical use." Law No. 86-FZ dated June 22, 1998
Ministry of Health and Social Development Russia, Roszdravnadzor MZiSR. Rational choice of drug names: guidelines. Order No. 429n of June 29, 2016 of the Ministry of Health of Russia "On approval Rules for the rational choice of the names of medicinal products for medical use ”.
Salo V.M. On the history of the opening of the first pharmacy in the Russian state. Pharmacy No. 1, 2003;
Federal Law of June 22, 1998 "On Medicines" No. 86-FZ.
Chupandina E.E., Slivkin A.I., Safonova State and prospects for the development of pharmaceutical management in Russia // Pharmacy. - 2006. - No. 5. - S. 16-18.
Yavorsky D.Ya. Pharmaceutical trade mark: the problem of choice // Pharmacy. - 2007. - No. 8. - S. 22-24.
Event Reporting System (FDA, CDER, MedWatch program, Office of Post-Marketing Drug Risk Assessment, National Cooidonating Counsil for Safe Medication Practices) / Phillips J. [et al.]. - JAMA, 1998, 279,1200-5.
Peculiarities of naming in the pharmaceutical business. // Kazakhstan Pharmaceutical Bulletin, 2009 http://pharmnews.kz/news/osobennosti_nejminga_v_f armbiznese / 2009-07-15-2411)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.